Varian Medical Systems, Inc. (VAR): Price and Financial Metrics

Varian Medical Systems, Inc. (VAR)

Today's Latest Price: $118.92 USD

0.43 (0.36%)

Updated Jul 10 6:30pm

Add VAR to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

VAR Stock Summary

  • VAR has a higher market value than 86.18% of US stocks; more precisely, its current market capitalization is $10,799,713,259.
  • Varian Medical Systems Inc's stock had its IPO on January 5, 1988, making it an older stock than 89.32% of US equities in our set.
  • The price/operating cash flow metric for Varian Medical Systems Inc is higher than 86.76% of stocks in our set with a positive cash flow.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Varian Medical Systems Inc are ATHM, DOX, FLIR, MKSI, and TRMB.
  • Visit VAR's SEC page to see the company's official filings. To visit the company's web site, go to
VAR Daily Price Range
VAR 52-Week Price Range

VAR Stock Price Chart Technical Analysis Charts

VAR Price/Volume Stats

Current price $118.92 52-week high $150.06
Prev. close $118.49 52-week low $89.62
Day low $117.16 Volume 297,937
Day high $118.97 Avg. volume 795,590
50-day MA $119.59 Dividend yield N/A
200-day MA $124.83 Market Cap 10.80B

Varian Medical Systems, Inc. (VAR) Company Bio

Varian Medical Systems designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions in the United States. The company operates in two segments, Oncology Systems and Imaging Components. The company was founded in 1948 and is based in Palo Alto, California.

VAR Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

Below please find a table outlining a discounted cash flow forecast for VAR, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Varian Medical Systems Inc ranked in the 17th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 78.83%. The most interesting components of our discounted cash flow analysis for Varian Medical Systems Inc ended up being:

  • Its compound free cash flow growth rate, as measured over the past 5.47 years, is -0.03% -- higher than only 24.86% of stocks in our DCF forecasting set.
  • VAR's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 46.59% of tickers in our DCF set.
  • As a business, Varian Medical Systems Inc experienced a tax rate of about 23% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than 87.89% of stocks generating free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

MYGN, ARA, EW, PRGO, and GMED can be thought of as valuation peers to VAR, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.

VAR Latest News Stream

Event/TimeNews Detail
Loading, please wait...

VAR Latest Social Stream

Loading social stream, please wait...

View Full VAR Social Stream

Latest VAR News From Around the Web

Below are the latest news stories about Varian Medical Systems Inc that investors may wish to consider to help them evaluate VAR as an investment opportunity.

Varian Wins "Best After-Sales Service Award for Radiotherapy Products" in China For Third Year In A Row

Varian (NYSE: VAR) today announced it received the "Best After-Sales Service Award for Radiotherapy Products" in the 2019 Chinese Medical Devices Industry Data and After-Sales Service Survey for the third year in a row. Varian also led in metrics of Market Share, Repurchasing Reference, and Net Promoter Score.

Yahoo | July 6, 2020

Dr. Cipto Mangunkusumo Hospital Treats Indonesia's First Patient on Varian's Halcyon System

Dr. Cipto Mangunkusumo Hospital, Jakarta has become the first hospital in Indonesia to treat patients using Varian's Halcyon™ system. The first patient, a 14 year old female, was treated for Hodgkin lymphoma.

Yahoo | July 1, 2020

Long-Term Results from SABR-COMET Further Demonstrate Effectiveness of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Metastatic Cancers

Long-term results of the Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Cancers (SABR-COMET) study published June 2, 2020 in the Journal of Clinical Oncology showed positive increases in overall survival for patients with multiple sites of metastasis when treated with stereotactic ablative radiotherapy (SABR) versus standard-of-care.1 Through the extended follow-up, the impact of SABR on overall survival was larger in magnitude than in the study's initial analysis published last year in The Lancet.2

Yahoo | June 25, 2020

Varian Medical Systems, Inc. (VAR): Hedge Funds Taking Some Chips Off The Table

In this article we will check out the progression of hedge fund sentiment towards Varian Medical Systems, Inc. (NYSE:VAR) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 […]

Yahoo | June 15, 2020

IBD Rating Upgrades: Varian Medical Systems Flashes Improved Technical Strength

Varian Medical Systems shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Yahoo | June 8, 2020

Read More 'VAR' Stories Here

VAR Price Returns

1-mo 5.01%
3-mo N/A
6-mo -18.79%
1-year -11.83%
3-year 13.43%
5-year 35.46%
YTD -16.26%
2019 25.33%
2018 1.94%
2017 23.80%
2016 11.11%
2015 -6.60%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9562 seconds.